Intellectual Property UK

  • June 01, 2026

    Visa Blocks 'Lovisa' Cosmetics TM Application In EU

    Visa has persuaded European Union officials to deny a Chinese individual's "Lovisa" trademark application, proving that shoppers could mistakenly think the logo is an extension of its "Visa" branding.

  • June 01, 2026

    Viral Labubu Toy Loses TM Protection To Turkish 'Bubu' Rival

    An Italian retailer has lost a trademark displaying the viral Labubu plush toy shown off by celebrities like Rihanna and David Beckham, after a Turkish stationery shop convinced European officials that shoppers were too accustomed to its earlier "Bubu" mark despite the Labubu toy's global craze. 

  • June 01, 2026

    Moldova Becomes 40th State To Join EU Patent Convention

    European officials said Monday that Moldova has officially become the 40th country to sign onto the European Patent Organization, giving businesses and inventors in the country broader access to patent protection after years of co-operation with the bloc.

  • June 01, 2026

    Budweiser Budvar Downs Aldi's 'Buval' Beer TM Hopes

    Czech brewer Budweiser Budvar has convinced the European Union to block Aldi's "Buval" trademark application, proving that drinkers could confuse the two brands in noisy bars and nightclubs.

  • June 01, 2026

    Honeywell Keeps Patent For Eco-Friendly Chemical Process

    Honeywell has persuaded a European appeals panel to uphold an amended version of its patent for a way of producing an environmentally friendly refrigerant chemical, defeating a Mexican rival's quest to void the patent entirely.

  • May 29, 2026

    Hitachi Can't Revive Bid To Patent Voltage-Surge Protector

    European appellate officials have rejected a Hitachi patent for a component that manages surge voltages in power transmission systems, ruling that there wasn't enough information allowing skilled engineers to make the two claimed versions. 

  • May 29, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen the billionaire who donated £5 million ($6.7 million) to Nigel Farage sue Ben Habib, the leader of far-right party Advance UK, for defamation; Mashreqbank bring claims against three subsidiaries of dissolved private equity giant Abraaj Group for commercial fraud; and the property and investment vehicle of the State of Kuwait be targeted by four real estate figures who filed a miscellaneous claim. Here, Law360 looks at these and other new claims in the U.K.

  • May 29, 2026

    Squire Patton's New EU IP Head Sets Sights On UPC And AI

    After some false starts, Squire Patton Boggs is handling its first dispute at the Unified Patent Court, and new European IP and technology chief Carlton Daniel could not be happier to see the firm through its new foray into European patent litigation.

  • May 29, 2026

    Nokia Drops UPC Claim Against Lotus Following Settlement

    Nokia has withdrawn its infringement claim against Lotus and other brands owned by Geely in a European court a week after the Finnish firm said it had settled all litigation with the Chinese electric automaker over patents covering smart-car technology.

  • May 29, 2026

    Ferrero Cracks Confectioner's Bid For 'Vlinder' TM

    Ferrero has persuaded European officials to block a Saudi Arabian confectioner from registering the trademark "Vlinder: Chocolate" after demonstrating that consumers would likely believe it was connected to Ferrero's established "Kinder" chocolate range.

  • May 28, 2026

    HSBC Defeats Most Claims In First Citizens' Poaching Suit

    A California federal judge has dismissed the bulk of First Citizens Bank & Trust Co.'s suit against HSBC alleging the latter induced a mass resignation and misappropriated trade secrets, saying the court still didn't have any jurisdiction over some defendants and that an amended complaint had not cured issues with a previously dismissed complaint.

  • May 28, 2026

    Roche Revives Patent For Heart Risk Monitor At EPO

    Roche has won a second chance at defending its patent for predicting heart failure, after an appellate board found that an earlier cardiac-screening study didn't undermine its intellectual property because it used other testing methods to reach different results. 

  • May 28, 2026

    Brown University Can't Patent Body Shape Guessing Tech

    European appellate officials have rejected a Brown University patent covering technology that guesses a person's body shape to help them shop online or achieve their fitness goals, ruling that it was obvious to provide real height and weight constraints for better accuracy. 

  • May 28, 2026

    Drugmaker Disputes Challenge To Pet Vomiting Treatment

    A Dechra unit has pushed back against rival drugmaker Krka's attempt to revoke its injectable formula for treating vomiting in cats and dogs, insisting the patent has remained valid from the outset. 

  • May 28, 2026

    Stanford Gives Up Cancer Treatment Patent In Europe

    Stanford University has relinquished its European patent for a type of cancer treatment following a challenge from Pfizer and Danish biotech company Genmab, an appeals panel found in a ruling released Thursday.

  • May 28, 2026

    Unauthorized Red Bull Sales Did Little Harm, Wholesaler Says

    A wholesaler has partially admitted that it infringed Red Bull's trademark over its name by selling the energy drinks without authorization abroad, but told a London judge that the scale of the infringement was being exaggerated and the damages awarded should be minimal. 

  • May 28, 2026

    Jellycat Hits Next, Hamleys With String Of Passing-Off Claims

    Jellycat has hit three retailers, including High Street giants Next and Hamleys, in a series of trademark infringement and passing-off claims at the High Court.

  • May 27, 2026

    Property Co. Says 'Praxis' TM Confusion Led To Bad Reviews

    A real estate management company has accused a rival of infringing its "Praxis" trademark, telling a London court that unhappy apartment block residents were confused by the brands and had written negative online reviews against the wrong company about rats and damp. 

  • May 27, 2026

    Toyota Told Century TMs Conflict With Plant IP Protections

    The European Union has trimmed Toyota's applications for three trademarks for its "Century" car brand, ruling that the name cannot appear on goods that conflict with various plant variety protections.

  • May 27, 2026

    Diageo Knocks Out Tech Co.'s 'Soul' TM For Beverages

    Guinness owner Diageo has convinced European officials to revoke a company's "Soul" trademark for beers and other beverages, as officials held the company had not provided evidence of commercial use in the last five years. 

  • May 27, 2026

    Pirelli Gets UPC Injunctions Against 2 Copycat Tire Makers

    Pirelli has obtained two injunctions against two rival tire makers that Europe's patent court ruled had copied Pirelli's special grooves on the tire's central strip, aimed at improving road grip for motorcycles. 

  • May 27, 2026

    Nestlé Defends Infant Formula Patent Against Danone Unit

    Nestlé has preserved a tweaked version of its European patent for infant formula that helps to tackle conditions such as obesity and diabetes, defeating an appeal from a Danone subsidiary which sought to void the patent entirely.

  • May 26, 2026

    Japanese Chemical Biz Beats Challenge To EU Resin Patent

    Japanese chemical giant Eneos has persuaded European officials to block Dow Chemical Co.'s challenge to its patent for a wired resin composition, with an appellate board finding that a skilled manufacturer would easily understand how to reproduce it.

  • May 26, 2026

    Google Defeats Film Distributor's 'Shorts' TM On Appeal

    A distributor of short films lost its appeal Tuesday seeking to force Google to drop its YouTube "Shorts" brand, as a London appeals court upheld a ruling that "shorts" had a broad and descriptive meaning that undermined the distinctiveness of the distributor's trademark.

  • May 26, 2026

    AstraZeneca Unit Keeps Cancer Therapy IP Despite Stada Jab

    An AstraZeneca unit can keep exclusively selling a cancer treatment combining two enzyme blockers, after an appellate board rejected a rival's claims that its ability to reduce common side effects in patients wasn't enough to merit patent protection.

Expert Analysis

  • UPC Decision Highlights Key Security Costs Questions

    Author Photo

    While the Unified Patent Court recently ordered NanoString to pay €300,000 as security for Harvard's legal costs in a revocation action dispute, the decision highlights that the outcome of a security for costs application will be highly fact-dependent and that respondents should prepare to set out their financial position in detail, says Tom Brazier at EIP.

  • IP Ruling Could Pave Way For AI Patents In UK

    Author Photo

    If implemented by the U.K. Intellectual Property Office, the High Court's recent ruling in Emotional Perception AI v. Comptroller-General of Patents, holding that artificial neural networks can be patented, could be a first step to welcoming AI patents in the U.K., say Arnie Francis and Alexandra Brodie at Gowling.

  • Why It's Urgent For Pharma Cos. To Halt Counterfeit Meds

    Author Photo

    With over 10.5 million counterfeit medicines seized in the EU in 2023, it is vital both ethically and commercially that pharmaceutical companies take steps to protect against such infringements, including by invoking intellectual property rights protection, says Lars Karnøe at Potter Clarkson.

  • Examining US And Europe Patent Disclosure For AI Inventions

    Author Photo

    As applicants before the U.S. Patent and Trademark Office and the European Patent Office increasingly seek patent protection for inventions relating to artificial intelligence, the applications may require more implementation details than traditional computer-implemented inventions, including disclosure of data and methods used to train the AI systems, say attorneys at Finnegan.

  • Incontinence Drug Ruling Offers Key Patent Drafting Lessons

    Author Photo

    In a long-awaited decision in Astellas v. Teva and Sandoz, an English court found that the patent for a drug used to treat overactive bladder syndrome had not been infringed, highlighting the interaction between patent drafting and litigation strategy, and why claim infringement is as important a consideration as validity, says George McCubbin at Herbert Smith.

  • EPO Decision Significantly Relaxes Patent Priority Approach

    Author Photo

    In a welcome development for patent applicants, a recent European Patent Office decision redefines the way that entitlement to priority is assessed, significantly relaxing the previous approach and making challenges to the right to priority in post-grant opposition proceedings far more difficult, say lawyers at Finnegan.

  • Why US Should Help European Efforts To Fix SEP Licensing

    Author Photo

    The European Commission's proposed reform of standard-essential patent licensing aims to fix a fundamental problem stemming from the asymmetry and obscurity of information about SEPs, and U.S. agencies exploring regulation of foreign regimes should support and improve these efforts, say David McAdams at Duke University and David Katz at WilmerHale.

  • Shifting From Technical To Clear Insurance Contract Wordings

    Author Photo

    Recent developments on insurance policies, including the Financial Conduct Authority's new consumer duty, represent a major shift for insurers and highlight the importance of drafting policies that actively improve understanding, rather than shift the onus onto the end user, say Tamsin Hyland and Jonathan Charwat at RPC.

  • What's In The Plan To Boost Germany's Commercial Litigation

    Author Photo

    Lawyers at Cleary discuss Germany's recent draft bill, which establishes commercial courts and introduces English as a court language in civil proceedings, and analyze whether it accomplishes the country's goal of becoming a more attractive venue for commercial litigation.

  • Bitcoin Case Highlights Advanced Age Of UK's IP Law

    Author Photo

    An appellate court's recent decision in a case involving the copyright of bitcoin's file format emphasizes the role of copyright protection in software, and also the challenges of applying decades-old laws to new technologies, say Marianna Foerg and Ben Bell at Potter Clarkson.

  • Future Paths For AI Inventorship After Justices' Thaler Denial

    Author Photo

    Anup Iyer at Moore & Van Allen examines the current and future state of AI inventorship in the wake of the U.S. Supreme Court's decision not to hear Thaler v. Vidal, including collaboration, international challenges, and the need for closer examination in research and development-intensive sectors.

  • EU Ruling Highlights Strategic Benefits Of Patent Appeals

    Author Photo

    The European Patent Office board of appeal recently reversed the examining board's ruling in an application by LG Electronics, highlighting how applicants struggling to escape conflicting objection traps at the examination level can improve their chances of a positive outcome with an appeal, says Andrew Rudhall at Haseltine Lake.

  • Series

    In A 'Barbie' World: Boosting IP Value With Publicity Machines

    Author Photo

    Mattel's history of intellectual property monitoring, including its recent challenge against Burberry over the "BRBY" trademark ahead of the "Barbie" film, shows how IP enforcement strategies can be used as publicity to increase brand value and inform potential collaborations, says Carly Duckett at Shepherd and Wedderburn.

  • UPC Revocation Actions Offer An Attractive Patent Strategy

    Author Photo

    As the Unified Patent Court gains momentum after an initial period of nervousness around the recently launched forum, more businesses may be starting to realize the value of running revocation actions as an alternative route to knocking out patents across Europe, say Oliver Laing and Georgia Carr at Potter Clarkson.

  • 5 Takeaways For Litigants From Early EU Patent Court Ruling

    Author Photo

    One of the first Unified Patent Court ex parte preliminary injunctions was recently granted in myStromer v. Revolt Zycling, demonstrating the court's ability to decide cases extremely quickly, but parties should be careful in phrasing their motions and sufficiently substantiating them to achieve the desired result, says Antje Brambrink at Finnegan.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.